Zobrazeno 1 - 10
of 304
pro vyhledávání: '"A. Manuprasad"'
Autor:
Nisha K. Jose, Biju Soman, Jissa V. Thulaseedharan, Bipin T. Varghese, Shaji Thomas, Jeremiah J. Tom, Narayanankutty Warrier, Manuprasad Avaronnan, Panniyammakal Jeemon
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 12, Iss 10, Pp 2501-2506 (2023)
Background: Lung cancer continues to be the leading cause of cancer-related deaths in men and women. A breakdown by level of economic development shows no differences in cancer deaths in men but a higher rate of lung cancer deaths in women in industr
Externí odkaz:
https://doaj.org/article/bb406f83a6e94a208eeefe76a7302ce8
Autor:
Goyal, Gautam, Singh, Ashish, Avaronnan, Manuprasad, Raut, Nirmal Vivek, Talreja, Vikas, Chandrasekharan, Arun, Gupta, Kushal, Bhosale, Bharat, Kothari, Rushabh Kiran, Parekh, Deevyashali, Poladia, Bhavesh Pradip, Ghosh, Joydeep, Talele, Avinash, Shrirangwar, Sameer, Karpe, Akshay
Publikováno v:
In The Lancet Regional Health - Southeast Asia May 2024 24
Autor:
Harsha Doddihal, Thomas Marron, Satheesh C T, Manuprasad Avaronnan, Rajnish Nagarkar, Vineet Govinda Gupta, Biju Benjamin, Nagaraj Gowda, Venkatesha Udupa, Nilanjana Biswas, Jatin Kadam, Priyanka Dhage, Adam Beltran, Nikhil Amin
Publikováno v:
HemaSphere, Vol 7, p e56696bb (2023)
Externí odkaz:
https://doaj.org/article/122bde7493454edca1558ecf07cae549
Publikováno v:
Journal of Cancer Research & Therapeutics; Jul-Sep2024, Vol. 20 Issue 5, p1524-1532, 9p
Autor:
Sithara Aravind, Jasmin Jose, Praveen Kumar Shenoy, Manuprasad Avaronnan, Sajith Babu Thavarool, Sangeetha K. Nayanar
Publikováno v:
South Asian Journal of Cancer, Vol 11, Iss 02, Pp 146-151 (2022)
Abstract Sithara Aravind Background Oral metronomic chemotherapy (OMCT) represents an emerging concept in cancer treatment involving frequent administration of chemotherapeutic drugs at doses below maximum tolerated doses and with no prolonged drug
Externí odkaz:
https://doaj.org/article/6a89698f47af473580ddb5b38b442cd1
Autor:
Kumar Shenoy, V. P. Praveen1, Manuprasad, Avaronnan1 drmanuprasad@gmail.com, Babu, Sajith2,3, Aravind, Sithara4, Narayanan, Vinin N.5, Nayanar, Sangeetha4, Balasubramanian, Satheesan2
Publikováno v:
Ecancermedicalscience. 2022, Vol. 16 Issue 1415-1493, p1-6. 6p.
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 3, Iss 1, Pp 13-18 (2020)
Introduction: Salvage chemotherapy followed by autologous stem cell transplantation is the standard of care in relapsed lymphoma. The optimal regimen for salvage is not defined. The combination of gemcitabine, dexamethasone, and cisplatin (GDP) is an
Externí odkaz:
https://doaj.org/article/fa7fdbb2b90b491a957a127ce732f5b8
Autor:
Avaronnan Manuprasad, Praveen Kumar Shenoy, Joneetha Jones, N V Vinin, Adarsh Dharmarajan, Geetha Muttath
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 3, Iss 1, Pp 69-73 (2020)
Introduction: Majority of the patients in low-to-middle income countries (LMICs) have no access to adjuvant trastuzumab due to financial constraints. Short-course (9 weeks) schedule of trastuzumab is a feasible alternative in this setting. The object
Externí odkaz:
https://doaj.org/article/cc2c694ac2394807abdbb95d21bb487d
Autor:
Nair, Chandran K., Avaronnan, Manuprasad, Shenoy, Praveen Kumar, Raghavan, Vineetha, Jayarajan, Priya, Rudrapathy, Parthiban, Duraisamy, Karthickeyan, Balasubramanian, Satheesan
Publikováno v:
In Current Problems in Cancer April 2021 45(2)
Publikováno v:
In Proceedings of the Combustion Institute 2021 38(2):3261-3268